Publicacions en què col·labora amb Francisco Gaytán Luna (4)

2014

  1. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: Implications for treatment of OHSS with dopamine receptor 2 agonists

    Fertility and Sterility, Vol. 102, Núm. 5, pp. 1468-1476.e1

  2. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: Implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists

    Fertility and Sterility, Vol. 101, Núm. 5

2011

  1. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: Implications for OHSS development and treatment

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 8, pp. 2484-2492

  2. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis

    Reproduction, Vol. 142, Núm. 5, pp. 745-755